Nephrology
Starting from
$1,500
Up to $8,000 depending on centre
Typical duration
5–14 days
Including pre-operative work-up
Partner hospitals
1
Vetted for outcome data & accreditation
Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications
Specialist investigation and treatment of secondary hypertension caused by renal artery stenosis, chronic kidney disease, or renal parenchymal disease, including renal artery angioplasty and stenting, advanced antihypertensive optimization, and underlying CKD management. Patients with difficult-to-control blood pressure gain access to experienced vascular nephrologists and interventional radiologists.
Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.
Renal Hypertension Treatment
Coordinated from
or message us on WhatsApp
No commitment required. Your data is never shared with third parties.
Most people with renal hypertension are managed with antihypertensive medication alone; renal artery angioplasty and stenting is reserved for carefully selected cases. Here is how the two approaches compare.
| Parameter | Medical Management Alone | Angioplasty & Stenting (Added to Medical Therapy) |
|---|---|---|
| What it involves | Antihypertensive medication (often several drug classes, including an ACE inhibitor or ARB where appropriate) with regular blood pressure monitoring and dose titration. | A catheter-based procedure to open a narrowed renal artery with a balloon and place a stent, performed in addition to ongoing antihypertensive medication. |
| Best suited for | Most patients with atherosclerotic renal artery stenosis, per the landmark CORAL trial, which found no added benefit from stenting for most people in this group. | Selected patients such as those with fibromuscular dysplasia, flash pulmonary edema, rapidly declining kidney function, or blood pressure that remains uncontrolled despite optimal medication. |
| Evidence for blood pressure control | Optimal medical therapy achieves blood pressure reductions similar to stenting plus medical therapy in the CORAL trial population. | The CORAL trial found stenting did not significantly improve blood pressure control or clinical outcomes beyond medical therapy alone for atherosclerotic disease. |
| Procedural risk | No procedural risk, as no catheter-based intervention is performed. | Carries procedural risks including artery injury, bleeding at the access site, contrast-related kidney effects, and (rarely) cholesterol embolization, per the American Heart Association. |
| Ongoing monitoring | Regular blood pressure checks and kidney function tests to guide medication adjustments over time. | Same ongoing blood pressure and kidney function monitoring as medical management, plus post-procedure imaging to confirm stent patency. |
The steps below outline a typical evaluation and treatment pathway for renal hypertension. Your nephrologist and interventional radiologist will confirm the exact plan based on your imaging and clinical picture.
Diagnostic workup and renal artery imaging
Blood pressure history, kidney function tests, and imaging such as renal artery Doppler ultrasound, CT or MR renal angiography identify whether renal artery narrowing or another kidney-related cause is contributing to hypertension.
Specialist review and treatment selection
A nephrologist and interventional radiologist review the imaging together to decide whether medical management alone is appropriate or whether angioplasty and stenting is likely to add benefit, based on the pattern of disease and your overall kidney function.
Intervention, if indicated
For selected patients, a catheter is guided from the wrist or groin artery to the narrowed renal artery under local anesthesia and sedation; the narrowing is widened with a balloon and a stent is placed to keep the artery open.
Medication titration and monitoring
Antihypertensive medication is adjusted based on your response, with regular blood pressure checks and kidney function tests to track progress, whether or not an intervention was performed.
If stenting was performed, patients are typically monitored overnight with checks on the catheter access site, blood pressure, and kidney function; patients on medical management alone have no procedure-related recovery.
Blood pressure and kidney function are reassessed and antihypertensive medication doses are adjusted; the access-site puncture (if a procedure was performed) typically heals within this period, per the American Heart Association.
Blood pressure response is tracked over several follow-up visits, since improvement after stenting (where performed) can continue to be assessed over weeks to months, and medication regimens are fine-tuned accordingly.
Long-term follow-up with regular blood pressure checks, kidney function tests, and periodic imaging (if a stent was placed) continues indefinitely, since renal hypertension and underlying kidney disease require lasting management, per KDIGO guidance.
Source: American Heart Association; KDIGO; Mayo Clinic; Cleveland Clinic. Individual recovery varies and is guided by your treating nephrologist.
Known Risks & Limitations
Source: American Heart Association; KDIGO; Mayo Clinic; Cleveland Clinic; the randomized CORAL trial. No procedure is without risk; your treating nephrologist will review your individual case.
Remote case review
Share your blood pressure history, medication list, and any prior imaging with our coordination team, who forward your case for an initial nephrology review of the likely underlying cause and treatment pathway.
Specialist matching
We match you with an accredited hospital offering nephrology, hypertension specialist, and interventional radiology services experienced in evaluating and treating renal hypertension.
Cost estimate and travel planning
Once your case is reviewed, we issue a consolidated cost estimate covering diagnostic imaging, specialist consultations, and angioplasty and stenting if indicated, and help plan a trip length that matches your likely pathway.
Diagnostic workup and treatment
You attend your imaging and specialist consultations, and, if a procedure is recommended and appropriate, proceed to angioplasty and stenting with ongoing blood pressure monitoring throughout your stay.
Follow-up and continuity of care
Before you depart, your treatment records, imaging, and optimized antihypertensive regimen are shared with your home-country physician so they can continue monitoring your blood pressure and kidney function.
Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.
| Country | Avg. cost | vs. cheapest |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $2,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $4,000 | +100%chevron_right |
Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.
Gurugram, India
Medanta Hospital branch. Located in Delhi NCR, it serves Gurugram Sector 14 and surrounding areas. Established in 2022, it operates 250 beds with 100 doctors across cardiology, oncology, haematology, neurology, orthopaedics and fertility, holds NABH and NABL accreditation, and offers procedures including liver transplantation and living-donor liver transplant.
100+
Specialists
250+
Beds
Secondary hypertension from renal causes should be suspected when: your blood pressure is difficult to control despite three or more medications; you developed hypertension at a young age (under 30); there is a significant difference in kidney size on imaging; blood pressure suddenly worsened after starting an ACE inhibitor or ARB (suggesting renal artery stenosis); or you have abnormal kidney function tests alongside hypertension. Our partner nephrologist-hypertension specialists will conduct a structured secondary hypertension workup including renal artery imaging, urinary catecholamines (to exclude phaeochromocytoma), aldosterone-renin ratio, and renal function testing to determine whether a treatable cause exists — a diagnosis that is often missed in under-resourced healthcare settings.
No fees. No commitment.
We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.
